vs
READING INTERNATIONAL INC（RDI）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
READING INTERNATIONAL INC的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.4倍（$50.3M vs $35.5M），READING INTERNATIONAL INC净利率更高（-5.1% vs -304.2%，领先299.1%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -14.2%），READING INTERNATIONAL INC自由现金流更多（$4.1M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 5.6%）
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
RDI vs RXRX — 直观对比
营收规模更大
RDI
是对方的1.4倍
$35.5M
营收增速更快
RXRX
高出695.9%
-14.2%
净利率更高
RDI
高出299.1%
-304.2%
自由现金流更多
RDI
多$51.4M
$-47.3M
两年增速更快
RXRX
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $50.3M | $35.5M |
| 净利润 | $-2.6M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -1.9% | -304.8% |
| 净利率 | -5.1% | -304.2% |
| 营收同比 | -14.2% | 681.7% |
| 净利润同比 | -14.5% | 39.6% |
| 每股收益（稀释后） | $-0.11 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RDIRXRX
| Q4 25 | $50.3M | $35.5M | ||
| Q3 25 | $52.2M | $5.2M | ||
| Q2 25 | $60.4M | $19.2M | ||
| Q1 25 | $40.2M | $14.7M | ||
| Q4 24 | $58.6M | $4.5M | ||
| Q3 24 | $60.1M | $26.1M | ||
| Q2 24 | $46.8M | $14.4M | ||
| Q1 24 | $45.1M | $13.8M |
净利润RDIRXRX
| Q4 25 | $-2.6M | $-108.1M | ||
| Q3 25 | $-4.2M | $-162.3M | ||
| Q2 25 | $-2.7M | $-171.9M | ||
| Q1 25 | $-4.8M | $-202.5M | ||
| Q4 24 | $-2.2M | $-178.9M | ||
| Q3 24 | $-7.0M | $-95.8M | ||
| Q2 24 | $-12.8M | $-97.5M | ||
| Q1 24 | $-13.2M | $-91.4M |
毛利率RDIRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率RDIRXRX
| Q4 25 | -1.9% | -304.8% | ||
| Q3 25 | -0.6% | -3327.6% | ||
| Q2 25 | 4.8% | -916.8% | ||
| Q1 25 | -17.2% | -1297.9% | ||
| Q4 24 | 2.6% | -4042.4% | ||
| Q3 24 | -0.6% | -377.1% | ||
| Q2 24 | -16.4% | -697.4% | ||
| Q1 24 | -16.7% | -698.4% |
净利率RDIRXRX
| Q4 25 | -5.1% | -304.2% | ||
| Q3 25 | -8.0% | -3135.3% | ||
| Q2 25 | -4.4% | -894.2% | ||
| Q1 25 | -11.8% | -1373.3% | ||
| Q4 24 | -3.8% | -3935.5% | ||
| Q3 24 | -11.7% | -367.5% | ||
| Q2 24 | -27.4% | -676.6% | ||
| Q1 24 | -29.4% | -662.4% |
每股收益（稀释后）RDIRXRX
| Q4 25 | $-0.11 | $-0.17 | ||
| Q3 25 | $-0.18 | $-0.36 | ||
| Q2 25 | $-0.12 | $-0.41 | ||
| Q1 25 | $-0.21 | $-0.50 | ||
| Q4 24 | $-0.11 | $-0.56 | ||
| Q3 24 | $-0.31 | $-0.34 | ||
| Q2 24 | $-0.57 | $-0.40 | ||
| Q1 24 | $-0.59 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.5M | $743.3M |
| 总债务越低越好 | $185.1M | $9.6M |
| 股东权益账面价值 | $-18.2M | $1.1B |
| 总资产 | $434.9M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资RDIRXRX
| Q4 25 | $10.5M | $743.3M | ||
| Q3 25 | $8.1M | $659.8M | ||
| Q2 25 | $9.1M | $525.1M | ||
| Q1 25 | $5.9M | $500.5M | ||
| Q4 24 | $12.4M | $594.4M | ||
| Q3 24 | $10.1M | $427.6M | ||
| Q2 24 | $9.3M | $474.3M | ||
| Q1 24 | $7.5M | $296.3M |
总债务RDIRXRX
| Q4 25 | $185.1M | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | $202.7M | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益RDIRXRX
| Q4 25 | $-18.2M | $1.1B | ||
| Q3 25 | $-12.1M | $1.0B | ||
| Q2 25 | $-7.7M | $919.1M | ||
| Q1 25 | $-8.1M | $933.9M | ||
| Q4 24 | $-4.4M | $1.0B | ||
| Q3 24 | $1.6M | $524.6M | ||
| Q2 24 | $6.5M | $584.4M | ||
| Q1 24 | $18.0M | $401.2M |
总资产RDIRXRX
| Q4 25 | $434.9M | $1.5B | ||
| Q3 25 | $435.2M | $1.4B | ||
| Q2 25 | $438.1M | $1.3B | ||
| Q1 25 | $441.0M | $1.3B | ||
| Q4 24 | $471.0M | $1.4B | ||
| Q3 24 | $495.7M | $726.5M | ||
| Q2 24 | $494.9M | $775.9M | ||
| Q1 24 | $494.9M | $557.8M |
负债/权益比RDIRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.3M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $4.1M | $-47.3M |
| 自由现金流率自由现金流/营收 | 8.2% | -133.1% |
| 资本支出强度资本支出/营收 | 0.3% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-2.9M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流RDIRXRX
| Q4 25 | $4.3M | $-46.1M | ||
| Q3 25 | $295.0K | $-117.4M | ||
| Q2 25 | $1.6M | $-76.4M | ||
| Q1 25 | $-7.7M | $-132.0M | ||
| Q4 24 | $8.0M | $-115.4M | ||
| Q3 24 | $1.3M | $-59.2M | ||
| Q2 24 | $-10.4M | $-82.2M | ||
| Q1 24 | $-2.8M | $-102.3M |
自由现金流RDIRXRX
| Q4 25 | $4.1M | $-47.3M | ||
| Q3 25 | $-246.0K | $-117.6M | ||
| Q2 25 | $1.2M | $-79.6M | ||
| Q1 25 | $-8.0M | $-133.8M | ||
| Q4 24 | $7.0M | $-116.7M | ||
| Q3 24 | $-1.1M | $-63.8M | ||
| Q2 24 | $-10.6M | $-83.4M | ||
| Q1 24 | $-4.7M | $-109.0M |
自由现金流率RDIRXRX
| Q4 25 | 8.2% | -133.1% | ||
| Q3 25 | -0.5% | -2272.5% | ||
| Q2 25 | 1.9% | -413.9% | ||
| Q1 25 | -19.8% | -907.4% | ||
| Q4 24 | 12.0% | -2567.7% | ||
| Q3 24 | -1.8% | -244.6% | ||
| Q2 24 | -22.7% | -578.5% | ||
| Q1 24 | -10.4% | -789.9% |
资本支出强度RDIRXRX
| Q4 25 | 0.3% | 3.5% | ||
| Q3 25 | 1.0% | 4.7% | ||
| Q2 25 | 0.6% | 16.4% | ||
| Q1 25 | 0.6% | 12.4% | ||
| Q4 24 | 1.7% | 28.6% | ||
| Q3 24 | 4.0% | 17.5% | ||
| Q2 24 | 0.5% | 8.2% | ||
| Q1 24 | 4.3% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
RXRX
暂无分部数据
